These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26868493)

  • 21. The role of inflammatory cytokines in diabetes and its complications.
    King GL
    J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiazolidinediones and inflammation.
    Consoli A; Devangelio E
    Lupus; 2005; 14(9):794-7. PubMed ID: 16218490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting innate immune mediators in type 1 and type 2 diabetes.
    Donath MY; Dinarello CA; Mandrup-Poulsen T
    Nat Rev Immunol; 2019 Dec; 19(12):734-746. PubMed ID: 31501536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
    Donath MY; Böni-Schnetzler M; Ellingsgaard H; Ehses JA
    Physiology (Bethesda); 2009 Dec; 24():325-31. PubMed ID: 19996363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting inflammation in the treatment of type 2 diabetes.
    Donath MY
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():193-6. PubMed ID: 24003937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines.
    Xie W; Du L
    Diabetes Obes Metab; 2011 Apr; 13(4):289-301. PubMed ID: 21205111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Type 2 diabetes and anti-inflammatory agents: new therapeutic prospects?].
    Esser N; Paquot N; Scheen AJ
    Rev Med Suisse; 2011 Aug; 7(306):1614-8, 1620. PubMed ID: 21972727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.
    Oliver E; McGillicuddy F; Phillips C; Toomey S; Roche HM
    Proc Nutr Soc; 2010 May; 69(2):232-43. PubMed ID: 20158940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory markers and cardiometabolic diseases.
    Esser N; Paquot N; Scheen AJ
    Acta Clin Belg; 2015 Jun; 70(3):193-9. PubMed ID: 26103538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control.
    Scheen AJ; Esser N; Paquot N
    Diabetes Metab; 2015 Jun; 41(3):183-94. PubMed ID: 25794703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension.
    Park H; Hasegawa G; Obayashi H; Fujinami A; Ohta M; Hara H; Adachi T; Tamaki S; Nakajima Y; Kimura F; Ogata M; Fukui M; Yoshikawa T; Nakamura N
    Clin Chim Acta; 2006 Dec; 374(1-2):129-34. PubMed ID: 16857181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabesity: an inflammatory metabolic condition.
    Schmidt MI; Duncan BB
    Clin Chem Lab Med; 2003 Sep; 41(9):1120-30. PubMed ID: 14598860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
    Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
    Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juniperus rigida Sieb. extract inhibits inflammatory responses via attenuation of TRIF-dependent signaling and inflammasome activation.
    Han JW; Shim DW; Shin WY; Kim MK; Shim EJ; Sun X; Koppula S; Kim TJ; Kang TB; Lee KH
    J Ethnopharmacol; 2016 Aug; 190():91-9. PubMed ID: 27260408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic neuropathy in the gut: pathogenesis and diagnosis.
    Azpiroz F; Malagelada C
    Diabetologia; 2016 Mar; 59(3):404-8. PubMed ID: 26643877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.
    Lee YS; Jun HS
    Mediators Inflamm; 2016; 2016():3094642. PubMed ID: 27110066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes.
    Chen S; Jiang H; Wu X; Fang J
    Mediators Inflamm; 2016; 2016():9340637. PubMed ID: 28003714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction.
    Yin J; Peng Y; Wu J; Wang Y; Yao L
    J Leukoc Biol; 2014 Jan; 95(1):47-52. PubMed ID: 24018354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.